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Effect of glucose, pyruvate, and insulin on type 1 angiotensin II receptor
expression in SV4O-immortalized rabbit proximal tubule epithelial cells.
Ambient glucose concentrations alter type 1 angiotensin II receptor
(AT1R) expression in renal tissues. The direction of change in AT1R
density may depend on the specific cell type and the capacity for that cell
type to use glucose as an energy substrate. Given the effects of angiotensin
II (Ang II) in proximal tubule epithelia, glucose-mediated fluctuations in
AT1R expression could significantly alter tubular Na-H exchange and
volume reabsorption. To determine if glucose influenced AT1R expression
in cultured proximal tubule epithelial cells, SV4O-immortalized rabbit
proximal tubule epithelial cells (RPTEC) were exposed to 25 mmol
(hi-glc) or 5 mmol glucose-containing serum-free medium (lo-gle) for
seven to nine days, with or without an alternative energy substrate,
pyruvate. AT1R expression, assessed by quantitative reverse-transcription
polymerase chain reaction and specific '251-Ang II binding, decreased in
lo-gic medium (% reduction AT1R mRNA expression: 52 8%; N = 6;
P < 0.005 vs. hi-glc; % reduction specific '251-Aiig II binding: 48 12%;
N = 12; P < 0.03 vs. hi-glc). AT1R mRNA expression and specific
1251-Ang II binding recovered to hi-glc levels following the addition of
pyruvate [60 mmoll to lo-glc cells. To ascertain if a growth factor that
increases glucose uptake in vivo also altered AT1R expression, RPTEC
were cultured in hi-glc medium with or without exogenous insulin [100
nM]. Insulin addition increased AT1R mRNA expression and specific
1251-Ang II binding in a concentration-dependent manner. However,
insulin (100 nM) addition to lo-glc cells did not significantly increase
specific 1251-Ang II binding. These results suggest that AT1R expression in
SV4O-immortalized rabbit proximal tubule cells is significantly affected by
the availability of energy substrate. Ultimately, changes in proximal tubule
AT1R expression, mediated by elevated glucose concentrations and
insulin, could contribute to sodium-dependent hypertension in the setting
of hyperinsulinemia and hyperglycemia.
Ambient glucose concentrations can affect many aspects of
renal cellular function including sodium-glucose (Na -Glc) co-
transport [1], protein glycosylation [2], cellular hypertrophy [3],
synthesis of transforming growth factor-a [I and matrix accumu-
lation [5]. Ambient glucose levels also affect type 1 angiotensin II
receptor (ATIR) expression in cells cultured from different sites
Key words; proximal tubule, glucose, angiotensin II receptor, pyruvate,
insulin.
Received for publication May 24, 1996
and in revised form February 24, 1997
Accepted for publication February 24, 1997
© 1997 by the International Society of Nephrology
in the kidney. AT1R expression was decreased in mesangial cells
exposed to elevated ambient glucose in culture [6]. Studies in
diabetic rats further demonstrated decreased glomerular and
proximal tubule AT1R expression compared to control animals
[7]. In contrast, cultured proximal tubule epithelial cells increased
AT1R density following exposure to elevated glucose concentra-
tions for 48 hours [81. Given the profound renal effects of
angiotensin II (Ang II), fluctuations in AT1R expression could
lead to alterations in vasoconstriction [9], mesangial cell contrac-
tility [10], and marked changes in tubular Na-H exchange and
volume reabsorption [11, 12].
Questions arising from these observations focus on the ability
for these various cell types to utilize glucose as an energy
substrate, in addition to morphologic and functional effects that
glucose has in these cells. In particular, cultured proximal tubule
epithelial cells shift their energy production from gluconeogenesis
to glycolysis [13, 141. Thus, energy substrates that enhance either
gluconeogenesis or glycolysis might also affect tubular cell AT1R
expression. Proximal tubule epithelial cells were exposed to high
glucose or low glucose-containing serum-free medium with or
without an alternative gluconeogenic/glycolytic substrate, pyru-
vate. AT1R expression was assessed by reverse transcription
polymerase chain reaction (RT-PCR) and specific 1251-Ang II
binding. In addition, to ascertain if a growth factor that increases
glucose uptake in vivo also affected AT1R expression, proximal
tubule epithelial cells cultured under the aforementioned condi-
tions were exposed to exogenous insulin.
METHODS
Materials
[a32IdCTP (3000 Ci/mmol) and ['25l]-angiotensin II (2200
Ci!mmol) were obtained from New England Nuclear (Boston,
MA, USA). Dulbecco's modified eagle media (DMEM), sodium
pyruvate, penicillin (10,000 units)-streptomycin (10 mg/ml) solu-
tion, trypsin-EDTA, angiotensin II, phosphate buffered saline,
bovine serum albumin, and insulin were obtained from Sigma (St.
Louis, MO, USA). Fetal calf serum was obtained from Hyclone
(Logan, UT, USA). Insulin-like growth factor I (IGF-I) was
purchased from Upstate Biotechnology Inc. (Lake Placid, NY,
USA). Losartan was provided by Dupont Merck (Wilmington,
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DE, USA) and CGP 42112A was obtained from Ciba-Geigy
(Base!, Switzerland).
Cell culture
SV40-transformed rabbit proximal tubule epithelial cells were
isolated and cultured as previously described [151. Cells were
grown in DMEM, 10% fetal calf serum, penicillin (100 U/mI) and
streptomycin (100 mg/mI) supplemented with 5 mmol (lo-gic) or
25 mmol glucose (hi-glc) for 5 to 7 days. Media was replaced with
serum-free DMEM supplemented with the same concentrations
of glucose and, either no pyruvic acid or pyruvic acid at the
concentrations indicated for 48 hours before cells were studied.
Total glucose exposure in the medium therefore was 7 to 9 days.
For studies using lo-gle and hi-glc medium, early passage cells
were utilized (passages 5 to 10). For studies examining the effects
of insulin or insulin-like growth factor-I on AT1R expression, later
passage cells were utilized (passages 25 to 35).
Specific '251-angiotensin II binding
Binding studies were performed as previously described using
[1251]-labeled Ang II and unlabeled Ang II [161. Insulin was
dissolved in 50 m acetic acid, 150 mvi NaCI, pH 3. IGF-I was
dissolved in acetic acid. After 48 hours of incubation in serum-free
medium, cells were treated with each reagent or equivalent
concentrations of acetic acid in serum-free media alone.
Cells were incubated for another 24 to 48 hours with additions
to the serum-free media every 12 hours. Plates were removed and
washed with PBS supplemented with 0.1% bovine albumin three
times then exposed to '251-Ang II in PBS-0.1% albumin with or
without unlabeled Ang II at 4°C for four hours. After the
appropriate incubation, cells were washed three times with PBS-
0.1% albumin and cell-associated radioactivity was determined
after digestion with 0.05 M NaOH. Radioactivity was measured in
a gamma counter (Beckmann 5500B). Specific binding was deter-
mined by subtracting the non-specific binding component mea-
sured in the presence of (1 jiM) unlabeled Ang II from total
'251-Ang II binding.
Quantitative polymerase chain reaction (PCR) of AT1 receptor
Total RNA was isolated by the acid guanidium thiocyanate-
phenol-chloroform method [171. Reverse transcription and poly-
merase chain reaction were performed as previously described
[15]. A deletion mutant, constructed by cutting rabbit AT1R clone
3 [151 with MscI and religating, served as an internal control for
quantitative PCR. The mutant plasmid then was linearized and
RNA transcribed. For PCR, total RNA (10 jig) and deletion
mutant AT1R RNA (100 pg) were mixed and reverse transcribed
using murine reverse transcriptase (First Strand eDNA Synthesis
Kit; Pharmacia, Piscataway, NJ, USA) and an AT1R-specific
primer. The resultant single strand eDNA mixture was amplified
in a Perkin Elmer GeneAMP 9600 PCR System using Taq
polymerase (Perkin Elmer/Cetus) in the presence of [a32]dCTP.
PCR was carried out for 35 cycles at 95°C for 20 seconds, 55°C for
30 seconds, and 72°C for 90 seconds, followed by a 10 minutes
extension at 72°C. The employed primers were upstream sense
primer, 5 '-TGGGAATA1TTGGGAACAGC-3' and downstream
anti-sense primer, 3'-GTGAATA'TTT'GGTGGGGAAC-5'. Am-
plification of intact and mutant AT1R mRNA by these primers
yielded 703 bp and 415 bp fragments, respectively. For normal-
ization, parallel samples measured amplification of f3-actin eDNA
using the primers, 5'-AACCGCGAGAAGATGACCCAGAT-
CATGTVJ'-3'; and 3 '-AGCAGCCGTGGCCATCTCTTGCTC-
GAAGTC-5' [15]. Following 4% agarose gel chromatography, the
bands corresponding to the PCR products from intact AT1R, the
deletion fragment, and /3-actin were excised and the radioactivity
determined by scintillation spectrometry.
Protein analysis
Proteins were quantitated by the method of Smith et al [18]
using BCA protein reagents (Pierce, Rockford, IL, USA).
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Fig. 1. (A). Quantitative RT-PCR analysis of RPTEC AT1R in cells
treated with variable glucose concentrations and pyruvate. Total RNA (10
sg) and deletion mutant AT1R RNA (100 pg) were mixed and reverse
transcribed using murine reverse transcriptase as described in the Meth-
ods section. The resulting single strand eDNA mixture then underwent
PCR as described in the presence of [a32]dCTP. The PCR products were
analyzed by gel chromatography (4% agarose), then excised and incorpo-
rated radioactivity analyzed by liquid scintillation spectrometry. Results
were calculated by the radioactivity ratio (AT1R/deletion mutant AT1R/
/3-actin), then normalized to control values and presented as mean SEM
-fold stimulation (N = 6 for hi-gic and lo-glc; N = 4 for lo-glc + pyruvate;
°P 0.0005 vs. hi-glc). (B) Specific 1251-Ang II binding in RPTEC treated
with variable glucose concentrations and pyruvate. RPTEC cultured as
described were incubated with '251-Ang II in the presence or absence of
unlabeled Ang II [1 JiM] as described in in the Methods section for
determination of specific '2l-Ang II binding. Data are mean SCM of
absolute cpm bound/mg protein for each condition (N = 10 for lo-glc and
hi-gic; N = 7 for lo-glc + pyruvatc; °P < 0.025 vs. hi-glc; *p < 0.02 vs.
lo-gic + pyruvate [60 mmol]).
1*
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Table 1. Pyruvate supplementation to lo-gic medium: Effect on
recovery of specific '251-Ang II binding (normalized to lo-gic medium)
Medium
[pyruvatel
(addition) % Binding
P Value
(vs. lo-gic) N
lo-glc 0 100 12
hi-glc 0 193 21 <0.03 14
lo-glc 5 mmol 97 8 NS 3
lo-glc 10 mmol 158 22 <0.05 5
lo-glc 30 mmol 150 36 <0.05 4
lo-glc 60 mmol 200 14 <0.02 7
Statistical analysis
Results are presented as mean SEM. Results of PCR experi-
ments and 1251-Ang II binding assays were normalized as percent-
age of control values. Binding data were analyzed using the
program, GraphPad Prism (Graph Pad Software, Inc., San Diego,
CA, USA). Statistical comparisons were analyzed with the pro-
gram StatView (Abacus Concepts, Berkeley, CA, USA), using
ANOVA and Student's t-test with the Bonferroni correction when
indicated. A P value <0.05 was considered statistically significant.
RESULTS
Effect of nutrients on proximal tubule AT1R expression
To determine if alterations in glucose concentration regulated
AT1 R mRNA expression in SV40-immortalized rabbit proximal
tubule epitheliat cells (RPTEC), these cells were cultured in
medium containing 25 mmol (hi-glc medium) or 5 mmol glucose
(lo-glc medium) and AT1R mRNA expression was examined by
quantitative RT-PCR.
Steady-state AT1R mRNA expression decreased 52 8% in
cells grown in lo-gle medium for 48 hours compared to cells grown
in hi-glc medium (Fig. 1A) (N = 6; P  0.0005 lo-glc vs. hi-glc
medium). Specific '251-Ang II binding studies correlated with
these findings. Cells grown in lo-gle medium for 48 hours dis-
played less specific '251-Ang II binding than cells cultured in hi-glc
medium (Fig. IB) (cpm bound/mg protein—lo-glc medium,
4843 2140 vs. hi-glc medium, 9322 1675; N = 10; P < 0.025).
This effect appeared secondary to a reduction in B,, (mean
values: hi-glc-118 fmol/mg protein vs. lo-glc-61 fmol/mg protein)
as the Kd for hi-glc and lo-gle were not significantly different
(hi-glc-3.1 nM; lo-glc-2.8 nM).
To determine if the decrease in AT1R expression was related to
decreased nutrient concentration in the media, pyruvate was
added to the lo-glc medium as an alternative energy substrate.
Pyruvate addition to lo-gie medium exerted a dose-dependent
recovery in specific 1251-Ang II binding in RPTEC compared to
RPTEC cultured in hi-gic medium (Table 1). Based on these data,
pyruvate [60 mmolj was used to determine further whether this
alternative energy substrate affected steady-state AT1R mRNA
levels in RPTEC. Pyruvate addition [60 mmolj to to-gte medium
increased steady-state AT1 R mRNA expression to values compa-
rable to those in cells grown in hi-gte medium (Fig. lÀ; -fold
stimulation normalized to hi-gic medium—lo-gic + pyruvate,
1.15 0.29; N = 4; P 0.05 vs. b-gte alone). Pyruvate addition
had no significant effect on AT1R steady-state mRNA expression
in cells grown in hi-glc medium (1.06 0.16; N = 3, NS vs. hi-gte
alone). Cells incubated with lo-glc medium + pyruvate (60 mmol)
also fully recovered specific 125l-Ang II binding compared to cells
0 0.5 1 1.5 2 2.5
Fold change steady state AT1 A mRNA
normalized to untreated control cells
Fig. 2. Quantitative RT-PCR analysis of RPTEC AT1R in cells treated
with insulin and IGF-I. Total RNA obtained from RPTEC cultured as
described in the presence or absence of insulin and IGF-I was reverse
transcribed in the presence of deletion mutant AT1R RNA (100 pg) as
described in the Methods section. The resulting single strand eDNA
mixture then underwent PCR in the presence of [a32]dCTP. The PCR
products were analyzed by gel chromatography (4% agarose), then excised
and incorporated radioactivity analyzed by liquid scintillation spectrome-
try. Results were calculated by the radioactivity ratio (AT1R/deletion
mutant AT1R/J3-actin), then normalized to control values and presented
as mean SEM -fold stimulation (N = 4 to 6 for each; *p 0.05 vs.
untreated; ** < 0.01 vs. untreated).
grown in ni-gte medium [Fig. IB; cpm bound/mg protein, lo-gle +
pyruvate (60 mmol) —9521 2174; N 7; P < 0.025 vs. to-gte
medium alone].
Effects of insulin on proximal tubule AT1R expression
To ascertain if insulin, a growth factor that affects glucose and
energy uptake, also modulated proximal tubule AT1R mRNA
expression, cells were incubated with insulin in the hi-gte medium
for 24 to 48 hours. Insulin has been shown to increase AT1R
expression in adrenal tissue [19]. RPTEC AT1R steady state
mRNA expression increased following insulin treatment in a
concentration-dependent manner (Fig. 2). Low concentrations of
insulin (1 nM) caused no significant change in AT1R mRNA
expression (1.2 0.27-fold stimulation vs. untreated, N = 4, NS).
However, higher concentrations of insulin increased AT1R
mRNA expression (insulin 10 nrvi, 1.5 0.2-fold; N = 5; P < 0.05;
insulin 100 nM, 1.93 0.3-fold; N 5; P < 0.01; insulin I xM,
1.59 0.34-fold; N = 6; P < 0.05).
The concentrations of insulin that stimulated the increase in
RPTEC AT1R mRNA expression suggested the possibility that
insulin was cross-reacting with an insulin-like growth factor-I
receptor (IGF-I). IGF-I has also previously been shown to
increase AT1R mRNA expression in cultured bovine adrenal
faseicutata-reticularis cells [19]. Therefore, RPTEC were treated
with IGF-I treatment (150 rig/mI) in serum-free medium and
AT1R mRNA expression was determined as above. IGF-l also
increased steady-state AT1R mRNA expression (1.75 0.35-fold;
N 4; P < 0.05).
Specific '251-Ang II binding studies were performed to deter-
mine if the increase in AT1R mRNA expression correlated with
Ins (1 tiM)
Ins (100 nM)
Ins (10 nM)
Ins (1 nM)
Control
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Medium addition cpm bound/mg protein
P value
(vs. ni-gic) N
Control no addition 4171 1706 12
Insulin 1 flM 4002 1912 NS 6
Insulin 10 nM 6891 1039 <0.05 6
Insulin 100 nM 7836 1276 <0.05 13
Insulin 10 psi 7275 1156 <0.005 12
IGF-I 150 ng/ml 5624 976 <0.05 5
increased receptor density (Table 2). These studies demonstrated
a dose-dependency that correlated with the RT-PCR results.
Insulin (1 nM) had no stimulatory effect (-fold change vs. un-
treated, 0.96 0.12; N = 6; NS), whereas insulin (10 nM)
augmented specific 1251-Ang II binding (1.65 0.22-fold; N = 6;
P < 0.05). The increase in specific 1251-Ang II binding was again
a result of changes in the Bmax (mean B,,axvalues—late passage
RPTEC control, 53 fmol/mg prot; insulin 10 nvt, 87 fmol/mg prot).
The K. for late passage RPTEC untreated and insulin-treated
were not significantly different (late passage RPTEC untreated,
4.2 nM; insulin-treated, 3.8 nM). Insulin 100 nM further increased
tubular cell specific '251-Ang II binding (1.87 0.25-fold; N 13;
P < 0.05) as did insulin (10 pIvi; 1.74 0.15-fold; N = 12; P <
0.005). The effect of IGF-I, though significant, was less pro-
nounced (1.34 0.1-fold; N = 5; P < 0.05).
To determine if the effects of insulin on RPTEC AT1R
expression were related to ambient glucose, RPTEC were cul-
tured in lo-glc serum-free medium with or without insulin (100
nM) for 48 hours. Cells then were assayed for specific 1251-Ang II
binding. Cells cultured in lo-gic displayed the expected decrease in
specific 1251-Ang II binding compared to cells cultured in hi-gic
medium (cpm bound/mg protein: hi-glc, 4455 723; N = 3; lo-glc,
3037 846; N = 3; P < 0.05 vs. hi-gic). However, insulin 100 nM
addition to cells cultured in lo-gic medium did not significantly
alter specific '251-Ang II (lo-glc + insulin, 3379 578; N =4; P <
0.05 vs. hi-glc; Fig. 3).
DISCUSSION
Recent studies examining the effects of elevated ambient
glucose in cultured renal epithelial cells [4, 5, 20] and glomerular
cells [3, 20, 21, 221 suggest that glucose can affect cellular
expression of matrix proteins and cytokines. The data herein
suggest that elevated ambient glucose also affects RPTEC Ang II
receptors. Specific 1251-Ang II binding and AT1R mRNA expres-
sion decreased in lo-glc medium compared to cells grown in hi-glc
medium. However, pyruvate supplementation to the lo-glc me-
dium "rescued" Ang II receptor expression to levels seen in hi-gic
medium. Growth factors that affect glucose, insulin and IGF-I also
increased specific 1251-Ang II binding and AT1R mRNA expres-
sion in RPTEC. However, nutrient availability appeared to be a
predominant factor in determining RPTEC AT1 R expression, as
insulin addition to cells cultured in lo-gic medium did not
stimulate a recovery of specific 125l-Ang II binding.
Our findings suggest that RPTEC AT1 R expression is influ-
enced by the concentration of energy substrate available to the
cell. This is in agreement with Wolf et aJ [81, who observed
increased AT1R density in an SV4O-immortalized murine proxi-
mal tubule cell line only after cells were switched from 100 mg/dl
hi-glc lo-glc Io+lns
Fig. 3. Specific '251-Ang II binding in RPTEC treated with lo-gic medium
with or without insulin. RPTEC cultured as described were incubated with
'251-Ang II in the presence of absence of unlabeled Ang II 1 pMI as
described in the Methods section for determination of specific 51-Ang II
binding. Data show mean SEM of absolute cpm bound/mg protein for
each condition (N = 3 for hi-glc and lo-glc; N = 4 for lo-glc + insulin;
*P < 0.05 vs. hi-glc).
glucose-containing growth medium to medium containing 450
mg/dl glucose. In our studies, pyruvate-supplemented lo-glc me-
dium led to a concentration-dependent increase in specific 125l
Ang II binding whereas glucose concentrations greater than 450
mg/dl did not significantly increase RPTEC specific 1251-Ang II
binding (N = 4, data not shown). This suggests that there may be
different thresholds for nutrient effects in RPTEC for AT1 R.
Our studies also determined that insulin and IGF-I treatment
increased RPTEC AT1R expression. Exogenous insulin and IGF-I
have been shown to increase AT1R expression in cultured bovine
adrenal fasciculata-reticularis cells [19] as well as cultured rat
mesangial cells [23]. However, the availability of energy substrate
for RPTEC appeared to be a more significant regulator of AT1R
expression, as insulin alone did not stimulate increased AT1R
expression in RPTEC cultured in lo-glc medium.
Other investigations in cultured renal cells have demonstrated
that elevated ambient glucose per se stimulates synthesis of
fibronectin, laminin, and other extracellular matrix components
[21, 22, 24, 25]. Elevated ambient glucose may exert these effects,
at least in part, by transcriptional regulation. Glucose-dependent
transcriptional activation has been previously demonstrated for
genes in cultured hepatoma cells [26], bovine aortic smooth
muscle cells [27], and vascular smooth muscle cells [28]. Metabolic
pathways also may be important in mediating nutrient-related
gene transcription. Glucosamine, a product of the hexosamine
synthetic pathway, is a potent stimulus for growth factor gene
expression in vascular smooth muscle cells [291. Thus, energy
substrates by themselves may affect gene expression. Whether any
of these mechanisms are, in fact, acting to alter RPTEC AT1 R
expression was not addressed in the present studies and will be the
subject of further investigation.
Hyperglycemia and hyperinsulinemia, the biochemical and hor-
monal abnormalities partially mirrored in these studies, affect the
in vivo development of hypertension through several potential
mechanisms, including increased peripheral vascular resistance
[301, increased sensitivity to vasoactive hormones [31], and in-
creased exchangeable sodium [32]. These last two factors may
provide a partial explanation for the impaired ability to excrete a
saline load early in the diabetic state [32].
Table 2. Effect of insulin and IGF-I on RPTEC AT1R specific '251-Ang
II binding
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Hyperglycemia and hyperinsulinemia may directly affect tubu-
lar cell function. Gesek and Schoolwerth demonstrated that
insulin stimulated proximal tubule cell Na-H exchanger activity
in normotensive and hypertensive rats [331 and hyperglycemia has
been shown to increase Na,K-ATPase activity and Na-myo-
inositol transport in tubular cell primary cultures [34, 35]. Proxi-
mal tubule AT1 R, in response to Ang II binding, significantly
influence renal Na and water reabsorption, affecting up to 15%
of all renal Na reabsorption [12]. Thus, glucose- or insulin-
mediated changes in proximal tubule AT1R expression could
profoundly affect exchangeable sodium.
Studies in diabetic rats have demonstrated that renal AT1R
expression can fluctuate in the diabetic state. Harker et al noted
that ambient glucose concentrations affected the expression of
components of the renin-angiotensin system in diabetic rats [36].
Other investigators also have demonstrated that glonierular Ang
II binding is decreased early in streptozotocin-induced diabetes, a
model of insulin deficiency, [7j as is proximal tubule AT1R
expression [371. However, the institution of insulin therapy nor-
malized Ang II binding to levels documented in control animals
[37]. These data suggested that appropriate glucose utilization
may be an important factor influencing renal AT1R expression.
In summary, the availability of energy substrate affected AT1 R
expression in RPTEC. Insulin and IGF-l also affected RPTEC
AT1R expression. However, the lack of an insulin-stimulatory
effect in the setting of decreased energy substrate suggested that
Fig. 4. RT-PCR analysis of RPTEC AT1R in
cells cultured in ni-gic or lo-glc medium with
or without pyruvate supplementation, insulin or
IGF-I. Total RNA obtained from RPTEC
cultured as described was reverse transcribed in
the presence of deletion mutant AT1R RNA
(100 pg) as described in the Methods section.
The resulting single strand cDNA mixture then
underwent PCR, and the PCR products were
analyzed by gel chromatography (4% agarose)
[lane 1, molecular wt markers; lane 2, lo-glc;
lane 3, lo-glc + pyruvate (5 mmol); lane 4, lo-
glc + pyruvate (60 mmol); lane 5, hi-glc; lane 6,
hi-gic + insulin (100 nM); lane 7, hi-glc + IGF-
1(150 nglml)]. For further standardization,
corresponding /3-actin PCR products are shown.
substrate availability takes precedence as a regulatory factor in
controlling RPTEC AT1R expression. These data suggest that the
effects of glucose and hormones, at least in RPTEC, must be
assessed in the context of nutrient availability to the cells, and
nutrient availability should therefore be a consideration when
investigating any presumed effect of "hyperglycemia" or "insulin
stimulation" in cultured cells.
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